Opendata, web and dolomites

ASTHMAPOC

Disposable nitric oxide POC (point-of-care) test for home care easy management of asthma in chronic patients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ASTHMAPOC" data sheet

The following table provides information about the project.

Coordinator
TECNOLOGIAS AVANZADAS INSPIRALIA SL 

Organization address
address: CALLE MIGUEL VILLANUEVA 2 6 PISO PUERTA 3
city: LOGRONO
postcode: 26001
website: http://www.itav.es/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://ario.fernandez
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2014
 Duration (year-month-day) from 2014-10-01   to  2015-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECNOLOGIAS AVANZADAS INSPIRALIA SL ES (LOGRONO) coordinator 50˙000.00

Map

 Project objective

The ultimate goal we seek in ASTHMAPOC project is to develop a “ready to the market” point-of-care disposable device for self-patient management of chronic asthma. According to WHO statistics more than 235 million people suffer from asthma worldwide. As for all other chronic diseases, effective management of asthma is full of challenges because of the difficulties in determining the appropriate treatment programs and the low adherence to control medications. This typically results in many patients non-effectively prevented from asthma exacerbations and the consequent unnecessary too often visits to emergencies. ASTHMAPOC aims providing a low-cost affordable solution to chronic asthmatic patients for self-management of their disease. Patients who self-test can have a better control over their chronic condition, and make therapeutic, behavioral, and environmental adjustments in accordance with advice from healthcare professionals. Our approach to achieve ASTHMAPOC goals is to develop a point-of-care device based on disposable electrochemical biosensors capable to determine the concentration of FENO (fractional exhaled nitric oxide). FENO emerged in the last decade as an important biomarker for asthma assessment and management. The clinical utility of FENO has been already validated to the extent that currently there are approved standards in US and EU (further details will be provided in section 1.3). However, only few point-of-care devices have been developed for clinical use (section 1.4), while there is no single product for self-patient management in the market. This niche market is the one we seek exploring with ASTHMAPOC, but in order to be successful in this market we need first to carry out an in-depth feasibility study.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASTHMAPOC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASTHMAPOC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More